Lebowitz; Peter F.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lebowitz; Peter F..The latest application filed is for "method of adjuvant cancer treatment".
- Lebowitz; Peter F. - Research Triangle Park NC
- Lebowitz; Peter F. - Collegeville PA
- Lebowitz; Peter F. - King of Prussia PA
- Lebowitz; Peter F. - Radnor PA
| Patent | Date |
|---|---|
| Method of Adjuvant Cancer Treatment App 20210060021 - Laquerre; Sylvie ; et al. | 2021-03-04 |
| Method of adjuvant cancer treatment Grant 10,869,869 - Laquerre , et al. December 22, 2 | 2020-12-22 |
| Method of Adjuvant Cancer Treatment App 20200054641 - Laquerre; Sylvie ; et al. | 2020-02-20 |
| Method of Adjuvant Cancer Treatment App 20180338979 - Laquerre; Sylvie ; et al. | 2018-11-29 |
| Combination App 20180214451 - Dumble; Melissa ; et al. | 2018-08-02 |
| Method of Adjuvant Cancer Treatment App 20170202842 - Laquerre; Sylvie ; et al. | 2017-07-20 |
| Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancer Grant 9,402,846 - Dumble , et al. August 2, 2 | 2016-08-02 |
| Combination App 20160143913 - Dumble; Melissa ; et al. | 2016-05-26 |
| Method of Adjuvant Cancer Treatment App 20150216868 - Laquerre; Sylvie ; et al. | 2015-08-06 |
| Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK Inhibitor App 20150147350 - Gerard; Catherine Marie Ghislaine ; et al. | 2015-05-28 |
| Combination App 20150094321 - DUMBLE; Melissa ; et al. | 2015-04-02 |
| Combination App 20140350039 - DUMBLE; Melissa ; et al. | 2014-11-27 |
| Combination App 20140309243 - DUMBLE; Melissa ; et al. | 2014-10-16 |
| Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer Grant 8,835,450 - Dumble , et al. September 16, 2 | 2014-09-16 |
| Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfo- namide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarbo Grant 8,796,298 - Dumble , et al. August 5, 2 | 2014-08-05 |
| Methods Of Treating Cancer App 20130231346 - Gilmer; Tona M. ; et al. | 2013-09-05 |
| Combination App 20120322817 - Dumble; Melissa ; et al. | 2012-12-20 |
| Combination App 20120283278 - Dumble; Melissa ; et al. | 2012-11-08 |
| Combination App 20120202835 - Dumble; Melissa ; et al. | 2012-08-09 |
| Combination App 20120196886 - Dumble; Melissa ; et al. | 2012-08-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 